Dare Bioscience, Inc.
Income Statement
| Line Item | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 |
|---|---|---|---|---|---|---|---|
| Revenue | — | — | $766.0K | — | $80.0K | $6.0K | $625.0K |
| Cost of Revenue | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — | — |
| Operating Expenses | |||||||
| Research & Development | $6.4M | $984.7K | $72.7K | $25.9M | $11.8M | $9.7M | $15.8M |
| SG&A Expense | $4.7M | $2.7M | $157.9K | $11.2M | $8.6M | $6.2M | $6.4M |
| Operating Income | $-16.9M | $-11.2M | $-630.6K | — | — | — | — |
| Operating Margin | — | — | -82.3% | — | — | — | — |
| Interest Expense | — | $322.6K | $42.1K | $2.4M | $1.1M | $1.5M | $567.0K |
| Pretax Income | $-16.8M | $-11.5M | $-673.0K | — | — | — | — |
| Income Tax Expense | $3.2K | $0 | — | — | — | — | — |
| Net Income | $-16.7M | $-11.5M | $-672.7K | $-39.6M | $-23.3M | $-17.1M | $-22.1M |
| Net Margin | — | — | -87.8% | — | -29,177.5% | -285,716.7% | -3,536.2% |
| EPS (Basic) | $-0.79 | $1.78 | $-0.10 | $-0.20 | $-0.20 | $-3.13 | $-4.55 |
| EPS (Diluted) | $-0.79 | $1.78 | $-0.10 | $-0.20 | $-0.20 | $-3.13 | $-4.55 |
| Shares Outstanding (Basic) | 22.8M | 6.5M | 6.7M | 218.8M | 161.0M | 6.3M | — |
| Shares Outstanding (Diluted) | 22.8M | 6.5M | 6.7M | 218.8M | 161.0M | 6.3M | — |
| Dividends Per Share | — | — | — | — | — | — | — |